In vivo diagnosis and therapeutic control tool of VEGF in retinal disorders
The technology comprises a method for determination of VEGF (vascular endothelial growth factor) concentration directly in vivo in the eye by use of an implantable, semi-permeable biosensor.
Further information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Iron-Nickel-Zirconium Alloy Trigger a New Superconductor Zirconide
Student project uncovers superconductivity in polycrystalline iron nickel zirconide Zirconide: A New Transition Metal Tokyo, Japan – Researchers from Tokyo Metropolitan University have discovered a new superconducting material. They combined…
Heart of the Matter: Effective Anti-Obesity Strategies to Protect Cardiovascular Health
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart failure, regardless of their body…
CO2 and Global Warming: How Soils and Plants Challenge Future Droughts
What will the future of our soils – and thus also the availability of water – look like under the influence of imminent climatic changes? An international study led by…